This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (47)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Henry A. Briele, MD; Craig W. Beattie, PhD; Salve G. Ronan, MD; Prabir K. Chaudhuri, MD; Tapas K. Das Gupta, MD, PhD

Arch Surg. 1983;118(7):800-803.

Abstract
• Most patients treated for cutaneous melanoma who have recurrent disease do so within the first ten years after primary diagnosis. This report covers seven patients with clinical stage I disease in whom local or regional recurrence developed 11 to 23 years after first treatment. Six of the seven patients were premenopausal at the time for primary diagnosis, suggesting that gonadal steroids may affect the natural history of cutaneous melanoma by lengthening the disease-free interval. The seventh patient was male. All seven of the patients had regional recurrence that was definitively treated by further surgery. Lymph node metastases occurred in six of these seven patients. After surgical retreatment, all patients lived for at least 2.5 years. Four remain alive, three disease free, and one with partially controlled systemic and regional disease. This study underlines the importance of continued long-term follow-up in patients treated for cutaneous melanoma.

(Arch Surg 1983;118:800-803)

Author Affiliations
From the Division of Surgical Oncology, Department of Surgery (Drs Briele and Das Gupta), and the Departments of Pathology and Dermatology (Dr Ronan), University of Illinois at Chicago; Cook County Hospital (Drs Briele and Das Gupta), Veterans Administration West Side Hospital (Drs Briele and Das Gupta), Chicago; and the Hektoen Institute for Medical Research, Chicago.

Footnotes
Accepted for publication Nov 12, 1982.

Reprint requests to Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, 840 S Wood St, Chicago, IL 60612 (Dr Briele).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hazard-Rate Analysis in Stage I Malignant Melanoma
Rogers et al.
Arch Dermatol 1986;122:999-1002.
ABSTRACT  

Late Relapse From Cutaneous Stage I Malignant Melanoma
Shaw et al.
Arch Surg 1985;120:1155-1159.
ABSTRACT  

Late Recurrence (Beyond Ten Years) of Cutaneous Malignant Melanoma: Report of Two Cases and a Review of the Literature
Koh et al.
JAMA 1984;251:1859-1862.
ABSTRACT